Immunome OverviewImmunome Net Income
Profitability analysis for IMNM.
Quarterly Net Income
-$53.84M
↓ 29.3% YoY
As of Mar 2026
Annual Net Income (TTM)
-$224.59M
↓ 9.5% YoY
Trailing 12 months ending Mar 2026
Average Net Income (Comparison Companies)
Net Income History
Net Income Comparison
Annual Net Income Growth Rate (%)
Loading...
Annual Net Income Growth (Absolute)
Loading...